# The Rare Co-occurrence of Clostridioides difficile Infection and Pseudomonas Meningitis in an Infant: A Case Report

**Authors:** Ia Khurtsilava, Darejan Kanjaradze, Ekaterine Gozalishvili, Tamar Gachechiladze, Teimuraz Mikeladze

PMC · DOI: 10.7759/cureus.87103 · Cureus · 2025-07-01

## TL;DR

A five-month-old infant had rare co-infections of C. difficile and Pseudomonas meningitis, highlighting the importance of early diagnosis and treatment in infants.

## Contribution

This case report emphasizes the rare but critical co-occurrence of CDI and Pseudomonas meningitis in infants and the need for prompt recognition.

## Key findings

- The infant showed improvement after treatment for C. difficile but required further intervention for Pseudomonas meningitis.
- Neuroimaging and lumbar puncture were essential for diagnosing Pseudomonas meningitis in this case.
- Early and aggressive treatment improved outcomes despite the rare and complex infections.

## Abstract

This case report presents a five-month-old infant who developed clinically manifested Clostridioides difficile (C. difficile) infection (CDI) and Pseudomonas aeruginosa (P. aeruginosa) meningitis. Initially diagnosed with pseudomembranous enterocolitis and treated with oral vancomycin, the child showed gastrointestinal improvement but continued to experience persistent fever, prompting further evaluation. Neuroimaging revealed ventriculomegaly, leading to a lumbar puncture that confirmed bacterial meningitis. Empiric antibiotics were initiated, and amikacin was added following CSF culture results that identified P. aeruginosa, resulting in significant clinical improvement. This report highlights the diagnostic challenges of P. aeruginosa meningitis in infants, particularly when complicated by secondary infections like CDI. Our objective is to raise awareness about the fact that although P. aeruginosa meningitis is extremely rare in the pediatric population and CDI is infrequently symptomatic in infants, early recognition and aggressive treatment can improve outcomes and reduce complications.

## Linked entities

- **Chemicals:** vancomycin (PubChem CID 14969), amikacin (PubChem CID 37768)
- **Species:** Clostridioides difficile (taxon 1496), Pseudomonas aeruginosa (taxon 287)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** nosocomial infections (MESH:D003428), hydrocephalus (MESH:D006849), Neurological infection (MESH:D007239), Bacterial meningitis (MESH:D016920), bronchiolitis (MESH:D001988), inflammation (MESH:D007249), traumatic (MESH:D014947), venous PH (MESH:D014647), acidemia (MESH:C537358), dehydrated (MESH:D003681), fever (MESH:D005334), neurological deficits (MESH:D009461), Clostridioides difficile (C. difficile) infection (MESH:D003015), colonization (MESH:D003108), Neisseria meningitidis (MESH:D006069), P. aeruginosa meningitis (MESH:D008580), gastrointestinal disorders (MESH:D005767), bacterial infection (MESH:D001424), hypovolemic shock (MESH:D012769), P. aeruginosa (MESH:D011552), Coma (MESH:D003128), CDI (MESH:D020790), diarrhea (MESH:D003967), head injuries (MESH:D006259), developmental delay (MESH:D002658), pseudomembranous colitis (MESH:D004761), sepsis (MESH:D018805), pertussis (MESH:D014917)
- **Chemicals:** meropenem (MESH:D000077731), vancomycin (MESH:D014640), K (MESH:D011188), dobutamine (MESH:D004280), Cl (MESH:D002713), Amikacin (MESH:D000583), NA (MESH:D012964)
- **Species:** Homo sapiens (human, species) [taxon 9606], Streptococcus pneumoniae (species) [taxon 1313], Streptococcus sp. 'group B' (species) [taxon 1319], Escherichia coli (E. coli, species) [taxon 562], Clostridioides difficile (species) [taxon 1496], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312663/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12312663/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312663/full.md

---
Source: https://tomesphere.com/paper/PMC12312663